Kezdőlap › Limfóma › Massachusetts › Boston
Limfóma klinikai vizsgálatok: Boston, MA
33 Limfóma vizsgálat keres résztvevőket Boston és környéke (kb. 30 mérföldes körzetben) helyszínein. Nyissa meg a vizsgálatot, hogy lássa, ki csatlakozhat, és hogyan léphet kapcsolatba a csapattal.
Hivatalos vizsgálati szöveg (angol)
Vizsgálatra keres résztvevőket? Emelje ki az oldal tetején — $99 / 30 nap →
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
Toborzás folyamatban1. fázis
- Beth Israel Deaconess Medical Center - Research, Boston
A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
Toborzás folyamatban2. fázis
- Dana-Farber Cancer Institute, Boston
A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship
Toborzás folyamatban
- Mass General Hospital, Boston
Increasing Resiliency Among Early Post-Treatment Lymphoma Survivors
Toborzás folyamatban
- Mass General Brigham, Boston
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Toborzás folyamatban1/2. fázis
- Dana Farber Cancer Institute., Boston
Epco, Zanu, Ritux for R/R FL or MZL
Toborzás folyamatban2. fázis
- Dana-Farber Cancer Institute, Boston
AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
Toborzás folyamatban1/2. fázis
- Research Site, Boston
- Research Site, Boston
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
Toborzás folyamatban1/2. fázis
- Dana-Farber Cancer Institute, Boston
Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
Toborzás folyamatban3. fázis
- Research Site, Boston
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
Toborzás folyamatban1/2. fázis
- Massachusetts General Hospital, Boston
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Toborzás folyamatban1/2. fázis
- Massachusetts General Hospital, Boston
Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy
Toborzás folyamatban4. fázis
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
The CARDIOPROTECT Trial
Toborzás folyamatban2. fázis
- Beth Israel Deaconess Medical Center, Boston
DALY II USA/ MB-CART2019.1 for DLBCL
Toborzás folyamatban2. fázis
- Dana Farber Cancer Institute, Boston
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
Toborzás folyamatban1/2. fázis
- Call for Information (Investigational Site 0026), Boston
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
Toborzás folyamatban1/2. fázis
- Dren Investigational Site, Boston
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Toborzás folyamatbanMegfigyeléses tanulmány
- Dana-Farber Cancer Institute, Boston
Remote Monitoring and Symptom Management Digital Application
Toborzás folyamatban
- Massachusetts General Hospital, Boston
Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy
Toborzás folyamatban
- Massachusetts General Hospital Cancer Center, Boston
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Toborzás folyamatban1/2. fázis
- Dana Farber Cancer Institute, Boston
Interrupting Sedentary Time to Improve Cardiometabolic Health and Toxicity in Patients With Lymphoma Receiving Chemotherapy: The iSTAND Trial
Toborzás folyamatban
- Dana Farber Cancer Institute, Boston
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Toborzás folyamatban2. fázis
- Dana-Farber Cancer Institute, Boston
Rituximab Plus Venetoclax in Front Line Marginal Zone Lymphoma
Toborzás folyamatban2. fázis
- Beth Israel Deaconess Medical Center, Boston
Odronextamab in Low Tumor Volume Advanced FL
Toborzás folyamatban2. fázis
- Beth Israel Deaconess Medical Center, Boston
Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy
Toborzás folyamatban2. fázis
- Beth Israel Deaconess Medical Center, Boston
A Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell Lymphoma
Toborzás folyamatban2. fázis
- Beth Israel Deaconess Medical Center, Boston
- Dana Farber Cancer Institute, Boston
BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell Lymphoma
Toborzás folyamatban2. fázis
- Beth Israel Deaconess Medical Center, Boston
- Dana-Farber Cancer Institute, Boston
Pembrolizumab + Chemotherapy in Newly Diagnosed PCNSL
Toborzás folyamatban1. fázis
- Brigham and Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
CONFIRM: Magnetic Resonance Guided Radiation Therapy
Toborzás folyamatban
- Brigham & Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
Avo In R/R And Previously Untreated MCL
Toborzás folyamatban1/2. fázis
- Beth Israel Deaconess Medical Center, Boston
- Dana-Farber Cancer Institute, Boston
Mosunetuzumab for CLL MRD Clearance
Toborzás folyamatban1/2. fázis
- Brigham & Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
A Phase 2 Study to Evaluate the Safety and Efficacy of Pacritinib in Relapsed or Refractory Waldenström Macroglobulinemia
Toborzás folyamatban2. fázis
- Dana Farber Cancer Institute, Boston
HEME Home Transfusion Program
Toborzás folyamatban
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Limfóma vizsgálatok más városokban
- Houston, TX34 tanulmány
- New York City, NY33 tanulmány
- Washington, DC23 tanulmány
- Baldwin Park, CA21 tanulmány
- Chicago, IL20 tanulmány
- Durham, NC17 tanulmány
- St. Louis, MO15 tanulmány
- Philadelphia, PA15 tanulmány
- Cleveland, OH14 tanulmány
- Edison, NJ12 tanulmány
- Atlanta, GA12 tanulmány
- Seattle, WA12 tanulmány
Egyéb vizsgálatok: Boston
- Mellrák111 tanulmány
- Nem kis sejtes tüdőrák90 tanulmány
- Rák (minden típus)86 tanulmány
- Kolorektális rák63 tanulmány
- Áttétes rák63 tanulmány
- Tüdőrák62 tanulmány
- Petefészekrák61 tanulmány
- Prosztatarák59 tanulmány
- Depresszió52 tanulmány
- Endometriális rák50 tanulmány
- Szívelégtelenség44 tanulmány
- Akut mieloid leukémia44 tanulmány
Forrás: ClinicalTrials.gov, adatok lekérve: 2026. okt. 5.. Minden vizsgálat saját alkalmassági feltételeket határoz meg; a döntést a vizsgálati csapat hozza meg.